|
| Status |
Public on Feb 01, 2016 |
| Title |
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
Genome binding/occupancy profiling by high throughput sequencing
Third-party reanalysis
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation(s) |
26944678 |
| Submission date |
Aug 24, 2015 |
| Last update date |
May 15, 2019 |
| Organization |
Ottawa Hospital Research Institute |
| Phone |
(613) 737-8899 -73255
|
| Department |
Cellular and Molecular Medicine
|
| Lab |
Ottawa Bioinformatics Core Facility
|
| Street address |
501 Smyth Rd.
|
| City |
Ottawa |
| State/province |
ON |
| ZIP/Postal code |
K1H 8L6 |
| Country |
Canada |
| |
|
| Platforms (1) |
| GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
|
| Samples (17)
|
| GSM1859757 |
H3K27me3 ChIP-seq TAL1-KD |
| GSM1859758 |
Input ChIP-seq TAL1-ctl |
| GSM1859759 |
TAL1-control RNA-seq, replicate 1 |
| GSM1859760 |
TAL1-control RNA-seq, replicate 2 |
| GSM1859761 |
TAL1-KD RNA-seq, replicate 1 |
| GSM1859762 |
TAL1-KD RNA-seq, replicate 2 |
| GSM1859763 |
UTX-control RNA-seq, replicate 1 |
| GSM1859764 |
UTX-control RNA-seq, replicate 2 |
| GSM1859765 |
UTX-KD RNA-seq, replicate 1 |
| GSM1859766 |
UTX-KD RNA-seq, replicate 2 |
| GSM1859767 |
J4-control RNA-seq, replicate 1 |
| GSM1859768 |
J4-control RNA-seq, replicate 2 |
| GSM1859769 |
J4-2uM RNA-seq, replicate 1 |
| GSM1859770 |
J4-2uM RNA-seq, replicate 2 |
|
| This SuperSeries is composed of the following SubSeries: |
| GSE64832 |
UTX inhibition as selective epigenetic therapy against TAL1-driven T cell acute lymphoblastic leukemia |
| GSE72298 |
H3K27 methylation changes in Jurkat cells in response to TAL1-KD |
| GSE72299 |
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment |
|
| Relations |
| BioProject |
PRJNA293693 |
Less...
More...